APA (7th ed.) Citation

LJ, X., LL, F., SC, L., CS, B., BC, X., XW, H., . . . WJ, T. (2026). Adaptive therapy for perioperative non-small cell lung cancer: Strategies guided by dynamic minimal residual disease adjustment. Translational oncology, 64, 102660. https://doi.org/10.1016/j.tranon.2025.102660

Chicago Style (17th ed.) Citation

LJ, Xie, Fu LL, Liu SC, Bai CS, Xu BC, He XW, Lin HF, Zeng YC, and Tang WJ. "Adaptive Therapy for Perioperative Non-small Cell Lung Cancer: Strategies Guided by Dynamic Minimal Residual Disease Adjustment." Translational Oncology 64 (2026): 102660. https://doi.org/10.1016/j.tranon.2025.102660.

MLA (9th ed.) Citation

LJ, Xie, et al. "Adaptive Therapy for Perioperative Non-small Cell Lung Cancer: Strategies Guided by Dynamic Minimal Residual Disease Adjustment." Translational Oncology, vol. 64, 2026, p. 102660, https://doi.org/10.1016/j.tranon.2025.102660.